Mefartabac: Programa médicofarmacéutico de tratamiento del tabaquismo. Protocolo y metodología de trabajo en la farmacia comunitaria

Galán Parra, M Dolores; Galán Parra, Isabel R; Román Alvarado, Jaime; Juárez Manzano, Javier; Vaquero Prada, Juan Pedro.
Pharm. care Esp ; 6(2): 82-88, abr.-jun. 2004. tab
Artículo en Español | IBECS (España) | ID: ibc-147553

Documentos relacionados

  1. The 2022 Ferno Award Address: CrEATE, an Efficient Crossover Evaluation of Addiction Treatment Efficacy.
  2. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
  3. Identification of Sociodemographic, Clinical, and Genetic Factors to Aid Alaska Native and American Indian People to Successfully Quit Smoking.
  4. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.
  5. Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms.
  6. Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.
  7. Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.
  8. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
  9. [Vareniklin: a safe treatment of tobacco dependency for cardiovascular patients].
  10. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.